| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
4e-11 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
8e-11 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
5e-10 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
9e-10 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-09 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-09 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-08 |
| mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
4e-08 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-08 |